Wolverine Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-37,926
| Closed | -$6.97M | – | 2498 |
|
|
2021
Q2 | $6.97M | Buy |
37,926
+5,428
| +17% | +$997K | 0.05% | 161 |
|
|
2021
Q1 | $4.97M | Buy |
32,498
+12,499
| +62% | +$1.91M | 0.04% | 171 |
|
|
2020
Q4 | $3.12M | Buy |
19,999
+17,440
| +682% | +$2.72M | 0.02% | 231 |
|
|
2020
Q3 | $292K | Buy |
2,559
+2,542
| +14,953% | +$290K | ﹤0.01% | 647 |
|
|
2020
Q2 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 1189 |
|
|
2017
Q3 | – | Sell |
-350
| Closed | -$42K | – | 1119 |
|
|
2017
Q2 | $42K | Buy |
+350
| New | +$42K | ﹤0.01% | 704 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1019 |
|
|
2016
Q1 | – | Sell |
-1,800
| Closed | -$343K | – | 1219 |
|
|
2015
Q4 | $343K | Sell |
1,800
-800
| -31% | -$152K | 0.01% | 596 |
|
|
2015
Q3 | $406K | Sell |
2,600
-100
| -4% | -$15.6K | 0.01% | 567 |
|
|
2015
Q2 | $488K | Hold |
2,700
| – | – | 0.01% | 538 |
|
|
2015
Q1 | $467K | Buy |
+2,700
| New | +$467K | 0.01% | 530 |
|
|
2014
Q4 | – | Sell |
-8,600
| Closed | -$1.43M | – | 1535 |
|
|
2014
Q3 | $1.43M | Buy |
+8,600
| New | +$1.43M | 0.03% | 310 |
|
|
2014
Q1 | – | Sell |
-6,100
| Closed | -$810K | – | 1579 |
|
|
2013
Q4 | $810K | Sell |
6,100
-2,100
| -26% | -$279K | 0.02% | 492 |
|
|
2013
Q3 | $952K | Buy |
8,200
+3,600
| +78% | +$418K | 0.02% | 455 |
|
|
2013
Q2 | $424K | Buy |
+4,600
| New | +$424K | 0.01% | 599 |
|